Skip to main content

Client News

Verona Pharma appoints Kathleen Rickard, MD, as chief medical officer to lead late stage clinical development of RPL554

3rd January 2019

Atriva Therapeutics announces first closing of series A financing round

3rd January 2019
There is no more content to load